Specifically, A549-hACE2+TMPRSS2 cells challenged with SARS-CoV-2 lentiviral pseudoparticles pre-treated with FH, significantly reduced viral infection by ~25% (Figure 2A). Here, TMPRSS2 is linked to viral infectious disease.